266 related articles for article (PubMed ID: 25779036)
1. Synthesis of [(18)F]FMISO in a flow-through microfluidic reactor: Development and clinical application.
Zheng MQ; Collier L; Bois F; Kelada OJ; Hammond K; Ropchan J; Akula MR; Carlson DJ; Kabalka GW; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):578-84. PubMed ID: 25779036
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling of [18F]altanserin - a microfluidic approach.
Ungersboeck J; Richter S; Collier L; Mitterhauser M; Karanikas G; Lanzenberger R; Dudczak R; Wadsak W
Nucl Med Biol; 2012 Oct; 39(7):1087-92. PubMed ID: 22633218
[TBL] [Abstract][Full Text] [Related]
3. The possibility of a fully automated procedure for radiosynthesis of fluorine-18-labeled fluoromisonidazole using a simplified single, neutral alumina column purification procedure.
Nandy S; Rajan MG; Korde A; Krishnamurthy NV
Appl Radiat Isot; 2010 Oct; 68(10):1937-43. PubMed ID: 20493720
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology.
Bouvet VR; Wuest M; Wiebe LI; Wuest F
Nucl Med Biol; 2011 Feb; 38(2):235-45. PubMed ID: 21315279
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Analysis of Dynamic
Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic radiosynthesis and biodistribution of [18 F] 2-(5-fluoro-pentyl)-2-methyl malonic acid.
Dewkar GK; Sundaresan G; Lamichhane N; Hirsch J; Thadigiri C; Collier T; Hartman MC; Vaidyanthan G; Zweit J
J Labelled Comp Radiopharm; 2013 May; 56(5):289-94. PubMed ID: 24285373
[TBL] [Abstract][Full Text] [Related]
7. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO).
Chang CW; Chou TK; Liu RS; Wang SJ; Lin WJ; Chen CH; Wang HE
Appl Radiat Isot; 2007 Jun; 65(6):682-6. PubMed ID: 17379530
[TBL] [Abstract][Full Text] [Related]
8. Automated synthesis and PET evaluation of both enantiomers of [¹⁸F]FMISO.
Revunov E; Jørgensen JT; Jensen AI; Hansen AE; Severin GW; Kjær A; Zhuravlev F
Nucl Med Biol; 2015 Apr; 42(4):413-9. PubMed ID: 25595134
[TBL] [Abstract][Full Text] [Related]
9. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
11. Fully automated one-pot synthesis of [18F]fluoromisonidazole.
Tang G; Wang M; Tang X; Gan M; Luo L
Nucl Med Biol; 2005 Jul; 32(5):553-8. PubMed ID: 15982586
[TBL] [Abstract][Full Text] [Related]
12. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).
Yuan H; Frank JE; Merrill JR; Hillesheim DA; Khachaturian MH; Anzellotti AI
Curr Radiopharm; 2016; 9(3):235-243. PubMed ID: 27562785
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Lee ST; Scott AM
Semin Nucl Med; 2007 Nov; 37(6):451-61. PubMed ID: 17920352
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic single vessel production of hypoxia tracer 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole ([18F]-FMISO).
Yokell DL; Leece AK; Lebedev A; Miraghaie R; Ball CE; Zhang J; Kolb H; Elizarov A; Mahmood U
Appl Radiat Isot; 2012 Oct; 70(10):2313-6. PubMed ID: 22871433
[TBL] [Abstract][Full Text] [Related]
15. Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by
Vera P; Thureau S; Chaumet-Riffaud P; Modzelewski R; Bohn P; Vermandel M; Hapdey S; Pallardy A; Mahé MA; Lacombe M; Boisselier P; Guillemard S; Olivier P; Beckendorf V; Salem N; Charrier N; Chajon E; Devillers A; Aide N; Danhier S; Denis F; Muratet JP; Martin E; Riedinger AB; Kolesnikov-Gauthier H; Dansin E; Massabeau C; Courbon F; Farcy Jacquet MP; Kotzki PO; Houzard C; Mornex F; Vervueren L; Paumier A; Fernandez P; Salaun M; Dubray B
J Nucl Med; 2017 Jul; 58(7):1045-1053. PubMed ID: 28254869
[TBL] [Abstract][Full Text] [Related]
16. Dose-on-demand production of diverse
Matesic L; Kallinen A; Greguric I; Pascali G
Nucl Med Biol; 2017 Sep; 52():24-31. PubMed ID: 28599133
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.
Kersemans V; Cornelissen B; Hueting R; Tredwell M; Hussien K; Allen PD; Falzone N; Hill SA; Dilworth JR; Gouverneur V; Muschel RJ; Smart SC
PLoS One; 2011; 6(11):e25911. PubMed ID: 22102855
[TBL] [Abstract][Full Text] [Related]
18.
McGowan DR; Macpherson RE; Hackett SL; Liu D; Gleeson FV; McKenna WG; Higgins GS; Fenwick JD
Med Phys; 2017 Sep; 44(9):4665-4676. PubMed ID: 28644546
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
Eschmann SM; Paulsen F; Bedeshem C; Machulla HJ; Hehr T; Bamberg M; Bares R
Radiother Oncol; 2007 Jun; 83(3):406-10. PubMed ID: 17543402
[TBL] [Abstract][Full Text] [Related]
20. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
